Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin vs Lactulose for Quality of Life in Hepatic Encephalopathy
NCT01842113Phase 4Terminated
- Sponsor
- Tampa General Hospital
- Start
- Apr 2013
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rifaximin in hepatic encephalopathy (HE), sponsored by Tampa General Hospital. Started Apr 2013; status: terminated.
02
Drugs
rifaximin
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT01842113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01842113.